AURINIA PHARMACEUTICALS INC.
Loading stock data...
Key Financial Metrics (TTM | FY 2025)
$283.06M
Revenue
$287.20M
Net Income
2.07
EPS (Diluted)
$182.50M
Free Cash Flow
Profitability
Gross Margin
88.46%
Operating Margin
37.06%
Net Profit Margin
101.47%
EBITDA
$138.94M
Returns & Efficiency
Return on Assets (ROA)
38.21%
Return on Equity (ROE)
49.40%
Gross Profit
$250.39M
Operating Income
$104.91M
Financial Health
Total Assets
$751.59M
Total Debt
-
Debt to Equity
0.29x
Current Ratio
5.25
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$2.07
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
#140, 14315 - 118 AVENUE
EDMONTON, AB T5L 4S6 |
| Phone | 250-744-2487 |
| Incorporated | None, None |
| EIN | 981231763 |
| Fiscal Year End | 1231 |
| Stockholders' Equity | $581.33M |
| Cash & Equivalents | $80.16M |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
SCHEDULE 13D/A
Amended Schedule 13D
Amendment to Schedule 13D
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-26
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-04
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
88.5%
Operating Margin
37.1%
Net Margin
101.5%
ROE
49.4%
ROA
38.2%
Leverage & Liquidity
Debt to Equity
0.29
Current Ratio
5.25
Total Debt
-
Total Assets
$751.59M
Stockholders' Equity
$581.33M
Income Statement (FY 2025)
Revenue
$283.06M
Gross Profit
$250.39M
Operating Income
$104.91M
Net Income
$287.20M
EPS (Diluted)
$2.07
Cash Flow (FY 2025)
Free Cash Flow
$182.50M
Cash & Equivalents
$80.16M
Revenue Growth
20.4%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...